These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6407988)

  • 41. Twin pregnancy and erythroblastosis.
    Beischer NA; Pepperell RJ; Barrie JU
    Obstet Gynecol; 1969 Jul; 34(1):22-9. PubMed ID: 4978195
    [No Abstract]   [Full Text] [Related]  

  • 42. Delayed anemia in erythroblastosis fetalis.
    Strand C; Polesky HF
    Minn Med; 1972 May; 55(5):439-41. PubMed ID: 4624082
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinico-statistical evaluation of the early outcome of neonatal jaundice].
    Ferrari G; Ballario R
    Minerva Pediatr; 1970 Jul; 22(28):1394-6. PubMed ID: 4995663
    [No Abstract]   [Full Text] [Related]  

  • 44. [Survey on neonatal jaundice].
    Josanpu Zasshi; 1974; 28(6/7):337-42. PubMed ID: 4216657
    [No Abstract]   [Full Text] [Related]  

  • 45. [Late anemia in hemolytic disease of the newborn].
    Molaro GL; Vazzoler G
    Minerva Pediatr; 1966 Nov; 18(35):2072-7. PubMed ID: 4969530
    [No Abstract]   [Full Text] [Related]  

  • 46. [Erythroblastosis neonatorum].
    Bube FW
    Med Lab (Stuttg); 1968 Jul; 21(7):149-57. PubMed ID: 4975602
    [No Abstract]   [Full Text] [Related]  

  • 47. Rh haemolytic disease of the newborn and Rh genotyping by RFLP--and allele-specific--PCR.
    Le Van Kim C; Colin Y; Brossard Y; Cartron JP
    Transfus Clin Biol; 1995; 2(4):317-24. PubMed ID: 8542030
    [No Abstract]   [Full Text] [Related]  

  • 48. SEROLOGICAL ASPECT OF HEMOLYTIC DISEASE OF NEWBORN.
    ISLAMI ZS
    Va Med Mon (1918); 1963 Oct; 90():530. PubMed ID: 14069389
    [No Abstract]   [Full Text] [Related]  

  • 49. [ABO blood groups and haemolytic disease of newborns--population-genetic analysis].
    Berberović L; Redzić A; Bojan S
    Med Arh; 2004; 58(3):141-2. PubMed ID: 15484851
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Morphological and some histo- and biochemical changes in the heart during fetal and neonatal hemolytic disease].
    Volchenko KL
    Vopr Okhr Materin Det; 1970 Oct; 15(10):15-21. PubMed ID: 4995466
    [No Abstract]   [Full Text] [Related]  

  • 51. Distribution of ABO and Rh D blood groups in the population of Poonch District, Azad Jammu and Kashmir.
    Khan MN; Khaliq I; Bakhsh A; Akhtar MS; Amin-ud-Din M
    East Mediterr Health J; 2009; 15(3):717-21. PubMed ID: 19731788
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnosis, prevention, and therapy in hemolytic disease of the newborn.
    Polesky HF
    Clin Lab Med; 1982 Mar; 2(1):107-22. PubMed ID: 6821161
    [No Abstract]   [Full Text] [Related]  

  • 53. [Neonatal diagnosis of materno-fetal isoimmunization. Preliminary data on the use of Coombs' test with capillary tube method].
    Dambrosio F; Caccamo ML; Clerici Bagozzi D; Magna GE
    Minerva Pediatr; 1970 Sep; 22(38):1889-92. PubMed ID: 4991425
    [No Abstract]   [Full Text] [Related]  

  • 54. [Current status of neonatal hemolytic disease caused by Rh incompatibility].
    Uhlig R; Menzel K
    Z Arztl Fortbild (Jena); 1986; 80(4):143-8. PubMed ID: 3087070
    [No Abstract]   [Full Text] [Related]  

  • 55. The distribution of ABO and Rh blood groups in the Tabuk region and Medina Munewera, Saudi Arabia.
    Ozsoylu S; Alhejaily M
    Turk J Pediatr; 1987; 29(4):239-41. PubMed ID: 3142127
    [No Abstract]   [Full Text] [Related]  

  • 56. Prevention of Rh immunization.
    de Almeida JM
    Acta Paediatr Scand; 1980 Nov; 69(6):777-8. PubMed ID: 6782827
    [No Abstract]   [Full Text] [Related]  

  • 57. [Hemolytic disease of the newborn with ABO incompatibities, its immediate and late sequelae].
    Frishman MM; Smirnova GD; Pavliuk GA
    Pediatr Akus Ginekol; 1976; (4):17-8. PubMed ID: 825817
    [No Abstract]   [Full Text] [Related]  

  • 58. [Determination of the ABO Rhesus blood group of the fetus in utero by examination of the epithelial cells of the amniotic fluid by immunofluorescence].
    Seigneurin R; Reboud P; Magnis R; Goullier A
    Ann Biol Clin (Paris); 1967; 25(7):913-7. PubMed ID: 4965532
    [No Abstract]   [Full Text] [Related]  

  • 59. [Hemolytic disease of the newborn caused by fetomaternal incompatibility].
    Escandé CA; Lorenzo y de Ibarreta J; Temesio N; Garófalo O; Pérez-Scremini A; Vila-Vidal P; Vilanova R
    Arch Pediatr Urug; 1965 Jul; 36(7):455-68. PubMed ID: 4954973
    [No Abstract]   [Full Text] [Related]  

  • 60. The prevention of Rh-haemolytic disease.
    Clarke CA
    Sci Basis Med Annu Rev; 1968; ():168-85. PubMed ID: 4970016
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.